Capricorn Fund Managers’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-321,721
Closed -$18.3M – 197
2026
Q2
$18.3M Buy
+321,721
New +$14.3M 1.44% 19

Other funds holding TVTX

Capricorn Fund Managers's TVTX Position: Q3 2026 in Review

Capricorn Fund Managers sold out of Travere Therapeutics (TVTX) in Q3 2026, closing a stake of 321,721 shares — an estimated $18.3M sold.

Capricorn Fund Managers first reported a position in TVTX in Q2 2026 and held it in 1 quarter. The position peaked at $18.3M in Q2 2026. 312 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Capricorn Fund Managers reported no remaining Travere Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Capricorn Fund Managers sold 321,721 Travere Therapeutics shares in Q3 2026, an estimated $18.3M.
  • Capricorn Fund Managers first reported a position in Travere Therapeutics in Q2 2026 and held it in 1 quarter.
  • Capricorn Fund Managers's Travere Therapeutics position peaked at $18.3M in Q2 2026.
  • 312 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.